Yanan Xu
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment.
Journal: CNS neuroscience & therapeutics
Published: September 05, 2025
Second-line treatment strategies of ulcerative colitis after conventional therapy failure: A systematic review and network meta-analysis of randomized controlled trials.
Journal: PloS one
Published: August 28, 2025
How was published evidence used in model-based cost - utility analysis for lung cancer?
Journal: Health economics review
Published: March 17, 2025
Evidence-based recommendations for the prophylactic use of antiseizure medications (ASMs) in neurosurgery: a systematic review of guidelines.
Journal: Journal of neurology
Published: September 18, 2024
Cost-effectiveness analysis of 11 pharmacotherapies for recurrent glioblastoma in the USA and China.
Cost-effectiveness analysis of 11 pharmacotherapies for recurrent glioblastoma in the USA and China.
Journal: Therapeutic advances in medical oncology
Published: November 20, 2023
Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis.
Journal: Frontiers in pharmacology
Published: March 22, 2023
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease.
Journal: CNS neuroscience & therapeutics
Published: August 24, 2022
iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.
Journal: Oncology reports
Published: April 02, 2019
A new approach for reducing beam hardening artifacts in polychromatic X-ray computed tomography using more accurate prior image.
Journal: Journal of X-ray science and technology
Published: March 23, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026